World News: 16:40 GMT Tuesday 13th March 2018. [EQS Group via SPi World News]
DGAP-News: BB BIOTECH AG / Key word(s): AGM/EGM
Media Release of March 13, 2018
BB Biotech AG: Shareholders at the general meeting vote in favor of all proposals and approve the dividend of CHF 3.30
All proposals of BB Biotech AG's Board of Directors were approved by its shareholders at the Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a dividend of CHF 3.30 per share. Payment will be made on March 19, 2018, the date of record is March 16, 2018 and the ex-dividend date is March 15, 2018.
Shareholders elected the previous board members Dr. Erich Hunziker, Chairman, Dr. Clive Meanwell and Prof. Dr. Dr. Klaus Strein to another one-year term of office.
TE Communications AG, Bleichestrasse 11, 9000 St. Gallen, Switzerland, Tel. +41 79 423 22 28
|Company:||BB BIOTECH AG|
|Phone:||+41 52 624 08 45|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart; SIX|
|End of News||DGAP News Service|
Read More: http://www.dgap.de/dgap/News/?eqsNewsID=1681003
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.